Safety & Side Effects
Side effects of OPZELURA
The most common side effects of OPZELURA include: pain or swelling in your nose or throat, diarrhea, bronchitis, ear infection, increase in a type of white blood cell (eosinophil) count, hives, inflamed hair pores (folliculitis), swelling of the tonsils (tonsillitis), and runny nose (rhinorrhea).
These are not all of the possible side effects of OPZELURA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Incyte Corporation at 1-855-463-3463.
- OPZELURA was studied in children as young as 12 years old. It is not known if OPZELURA is safe or effective in children under 12 years of age.
- OPZELURA is for use on the skin only. Do not use in your eyes, mouth or vagina.
- Don't use OPZELURA if you are allergic to ruxolitinib or any of the ingredients in OPZELURA. See the Medication Guide for a complete list of ingredients in OPZELURA.
- OPZELURA may cause serious side effects including serious infections, cancer and immune system problems, blood clots, low blood cell counts, and increases in cholesterol.
- In people who've taken JAK inhibitors by mouth, an increased risk of death has happened.
- In people with cardiovascular risk factors, who are current or past smokers, there is an increased risk of major cardiovascular events in people using JAK inhibitors for inflammatory conditions.
It’s important to discuss both the benefits and the safety considerations with your healthcare provider before starting any medication.
Please read the Important Safety Information for OPZELURA below.
Working with your healthcare provider
Finding a provider that understands your needs can help you feel confident in your care. Remember to be open and honest with them about your symptoms and how eczema impacts you, so they can create a treatment plan that works for you.Learn more